Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer ; volume:5 ; number:1 ; day:16 ; month:9 ; year:2010 ; pages:1-6 ; date:12.2010
Radiation oncology ; 5, Heft 1 (16.9.2010), 1-6, 12.2010
- Urheber
-
Schmitz, Matthew D.
- Beteiligte Personen und Organisationen
-
Padula, Gilbert DA
Chun, Patrick Y.
Davis, Alan T.
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-5-80
- URN
-
urn:nbn:de:1111-2016072612876
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schmitz, Matthew D.
- Padula, Gilbert DA
- Chun, Patrick Y.
- Davis, Alan T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Androgen receptor expression in the clinically localized prostate cancer
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: a meta-analysis
Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer
Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer
Androgen receptor expression in the clinically localized prostate cancer
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: a meta-analysis
Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer
Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer
Androgen receptor expression in the clinically localized prostate cancer
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: a meta-analysis
Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer